Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Pre-targeted delivery of a tetrazinylated albumin–zinc(II) porphyrin complex for tumor photodynamic therapy
Zheng Huanga,
Yinxing Miao
a,
Xiaolei Zhao*ab and
Deju Ye*a
aState Key Laboratory of Analytical Chemistry for Life Sciences, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, China
bSchool of Chemical Engineering and Materials, Changzhou Institute of Technology, Changzhou, 213032, China
First published on 16th June 2026
Abstract
Correction for ‘Pre-targeted delivery of a tetrazinylated albumin–zinc(II) porphyrin complex for tumor photodynamic therapy’ by Zheng Huang et al., Chem. Commun., 2026, 62, 1201–1205, https://doi.org/10.1039/D5CC05967D.
The authors regret that the incorrect images were included as Fig. S20 and S25 in the Supplementary Information file of the original article. The correct versions of Fig. S20 and S25 are presented below.
Fig. S20 Live/dead cell staining images of 4T1 cells after various treatments. Scale bar: 40 µm.
Fig. S25 Representative raw and zoomed-in H&E staining images of major organs including heart, liver, spleen, lung and kidney collected from mice post different treatments. The corresponding cropped and zoomed-in areas are outlined in blue boxes. No obvious organ damage or lesion was observed for nanoparticles treated mice.
The Supplementary Information of the original article has been updated to reflect these changes.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2026 |